Pharmaceutical composition for inducing apoptosis comprising a fusion protein between bfl-1 and green fluorescent protein or a gene encoding same

摘要

A pharmaceutical composition comprising a fusion protein between green fluorescent protein and Bfl-1 protein or a gene encoding the fusion protein, as well as a pharmaceutically acceptable carrier, is capable of efficiently inducing apoptosis and useful for treating cancer or cell hyperplasia.